Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer Stage I”

235 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 235 results

Not applicableEnded earlyNCT02494635
What this trial is testing

Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer

Who this might be right for
Bladder Papillary Urothelial CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+5 more
University of Southern California 4
Early research (Phase 1)Study completedNCT02300610
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Early research (Phase 1)Study completedNCT01976741
What this trial is testing

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Who this might be right for
Neoplasms
Bayer 168
Testing effectiveness (Phase 2)Ended earlyNCT03637803
What this trial is testing

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Who this might be right for
OncologySolid TumorNon Small Cell Lung Cancer+3 more
4D pharma plc 63
Early research (Phase 1)Study completedNCT00313599
What this trial is testing

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsBreast Cancer+6 more
University of California, San Francisco 28
Testing effectiveness (Phase 2)Study completedNCT00002917
What this trial is testing

Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

Who this might be right for
Bladder Cancer
Mary Babb Randolph Cancer Center at West Virginia University Hospitals
Large-scale testing (Phase 3)Study completedNCT00003814
What this trial is testing

Eflornithine in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 450
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT01016639
What this trial is testing

Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer

Who this might be right for
Stomach CancerGall Bladder CancerBile Ductus Cancer+2 more
Lund University Hospital 106
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Large-scale testing (Phase 3)Study completedNCT00729287
What this trial is testing

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
KU Leuven 276
Early research (Phase 1)Study completedNCT00635336
What this trial is testing

Novel Peptide Vaccination for Patients With Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
Iwate Medical University 20
Not applicableStudy completedNCT04885309
What this trial is testing

Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours

Who this might be right for
Bladder Cancer Stage 0Bladder Cancer Stage I
Ankara Training and Research Hospital 104
Early research (Phase 1)Active Not RecruitingNCT00479128
What this trial is testing

Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors

Who this might be right for
Solid TumorUrethral Cancer
M.D. Anderson Cancer Center 80
Not applicableLooking for participantsNCT07302230
What this trial is testing

Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial

Who this might be right for
Localized Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more
University of Washington 100
Large-scale testing (Phase 3)UnknownNCT01094964
What this trial is testing

Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
Cancer Research Campaign Clinical Trials Centre 242
Large-scale testing (Phase 3)Study completedNCT00004154
What this trial is testing

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 111
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Load More Results